BIOSENTA Inc. obtains DIN number for sale of Zeromold

TORONTO, Sept. 19, 2012 /CNW/ - BIOSENTA INC. (CNSX: ZRO) (the "Company").  The Company is pleased to announce that it has obtained a Drug Identification Number from Health Canada, Therapeutic Products Directorate, for "Zeromold", the Company's retail anti-microbial product.  The Company has commenced manufacturing  Zeromold and expects to fill and ship its first order, for approximately $600,000, to its exclusive Canadian distributor, F.T.R. Products Group Inc. in the coming weeks.  F.T.R. Products Group is one of Canada's leading importer, manufacturer and distributor of home improvement products, including plumbing, bath, electrical, hardware, cleaning solutions and seasonal merchandise.

"This is an exciting time for the Company", said Bruce Lewis, the President & Chief Executive Officer of Biosenta. "The Company has successfully developed a new and unique line of business in a little over a period of one year with the help and support of its many investors, its directors and employees and its suppliers and distributor.  We look forward to developing and expanding the product line."

"We are looking forward to fulfilling our pre-orders for Zeromold and successfully launching the product right across Canada", said Frank Curcio, President, F.T.R. Products Group Inc.

About  BIOSENTA Inc.

BIOSENTA Inc.'s line of retail anti-microbial products will effectively kill mould, bacteria and fungi on contact and prevent re-growth. These products address the demand created by the mounting health and environmental concerns. Mould can affect the immune system, nervous system, liver, kidneys, blood and cause brain damage.

BIOSENTA will also manufacture and distribute an anti-microbial filler.  Calcium Carbonate is one of the most common fillers used industrially. It is susceptible like other fillers that hold moisture to attracting mould. Annual global revenue in the calcium carbonate filler industry approximates 140 billion dollars. BIOSENTA will produce anti-microbial filler that performs 'filling' and 'bulking' functions like calcium carbonate. BIOSENTA's filler product will not attract moisture and consequently mould infestation.  BIOSENTA's filler with its anti-microbial high ph core in individual particles will enhance commercial product life and eradicate a broad spectrum of known bacteria, fungi, algae and other micro-organisms by suppression of their reproduction.

Forward-Looking Information

This release may contain forward-looking statements information and statements which constitute "forward-looking information" under Canadian securities law and which may be material regarding, among other things, the Company's beliefs, plans, objectives, estimates, intentions and expectations with respect to its capital and funding plans.  Inherent in the forward-looking information and statements are known and unknown risks, uncertainties and other factors beyond the Company's ability to control or predict, which give rise to the possibility that the Company's predictions, forecasts, expectations or conclusions will not prove to be accurate, that its assumptions may not be correct and that the Company's plans, objectives and statements will not be achieved.  Actual results or developments may differ materially from those contemplated by the forward-looking information and statements. Consequently, undue reliance should not placed on such forward-looking statements.

On behalf of the Board of Directors of BIOSENTA Inc.

Bruce Lewis
Chairman

The CNSX has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release. Neither the CNSX nor its Regulation Services Provider (as such term is defined in the policies of the CNSX) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: BIOSENTA Inc.